Video Experimental Relacionado
Updated: Aug 16, 2026
07:05
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
Un sitio de unión de opiáceos en el cerebro de la rata es altamente selectivo para 4,5-epoxymorphinansans
Science (New York, N.Y.)
|September 16, 1983
Resumen
Los investigadores descubrieron un nuevo sitio lambda en el cerebro de la rata, distinto de los receptores de opiáceos conocidos. Este sitio muestra propiedades únicas de unión para ciertos compuestos opioides, lo que sugiere un nuevo objetivo para la investigación farmacológica.
Área de la Ciencia:
- Neurofarmacología y Neurofarmacología.
- Estudios de unión al receptor.
Sus antecedentes:
- Se conocen varios tipos de receptores opiáceos.
- Los receptores de opiáceos son cruciales en la modulación del dolor y la adicción.
Objetivo del estudio:
- Para caracterizar un nuevo sitio de unión en el cerebro de la rata, denominado el sitio lambda.
- Para investigar las distintas propiedades del sitio lambda en comparación con los receptores opiáceos establecidos.
Principales métodos:
- Ensayos de unión in vitro utilizando homogenatos del cerebro de rata.
- Estudios de unión selectiva de ligandos con 4,5-epoximorfinanos como la naloxona y la morfina.
Principales resultados:
- El sitio lambda muestra selectividad para 4,5-epoxymorphinans.
- Se observó una alta afinidad por la naloxona in vivo e in vitro, pero disminuyó rápidamente in vitro.
- La distribución regional del sitio lambda difiere significativamente de los receptores de opiáceos clásicos.
Conclusiones:
- El sitio lambda representa un subtipo distinto del receptor de opiáceos con características farmacológicas únicas.
- Su rápida conversión in vitro sugiere complejos mecanismos reguladores.
- La distribución única implica funciones especializadas en el sistema nervioso central.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:28Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...